FeaturedNeurosciencePsychology·May 20, 2022·3 min readNovel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive DisordersA preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment.Read More